A Elis
Overview
Explore the profile of A Elis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Elis A, Leventer-Roberts M, Bachrach A, Lieberman N, Durst R, Knobler H, et al.
QJM
. 2019 Dec;
113(6):411-417.
PMID: 31883017
Background: Familial hypercholesterolemia (FH) is an under-diagnosed condition. Aim: We applied standard laboratory criteria across a large longitudinal electronic medical record database to describe cross-sectional population with possible FH. Methods:...
3.
Edel Y, Mamet R, Snast I, Kaftory R, Mazor S, Hodak E, et al.
J Eur Acad Dermatol Venereol
. 2019 Jul;
34(1):184-187.
PMID: 31264284
Background: From a dermatologist's perspective, there are four major types of cutaneous porphyrias (CPs): porphyria cutanea tarda (PCT), erythropoietic protoporphyria (EPP), variegate porphyria (VP) and hereditary coproporphyria (HCP). Scarce data...
4.
5.
Atamna A, Suki M, Kenaany H, Elis A
QJM
. 2018 Apr;
111(7):461-465.
PMID: 29648661
Background: The treatment of atrial fibrillation (AF) includes anticoagulation (AC) therapy to prevent systemic emboli. Until recently, warfarin was the main AC agent, while in recent years, the new oral...
6.
Atamna A, Elis A, Gilady E, Gitter-Azulay L, Bishara J
Eur J Clin Microbiol Infect Dis
. 2016 Nov;
36(3):585-591.
PMID: 27864622
Obesity is associated with co-morbidities and increased risk of acquiring infections with worse outcomes. Paradoxically, a few studies indicate that obesity may have a decreased mortality in hospitalized patients with...
7.
Atamna A, Yahav D, Eliakim-Raz N, Goldberg E, Ben-Zvi H, Barsheshet A, et al.
Eur J Clin Microbiol Infect Dis
. 2016 Feb;
35(5):779-84.
PMID: 26864041
Unlabelled: Several studies have shown an association between exposure to statins and favorable clinical outcomes for various types of infections. We aimed to assess the impact of statin use on...
8.
Blaier O, Lishner M, Elis A
J Clin Pharm Ther
. 2011 Mar;
36(3):336-41.
PMID: 21414023
What Is Known And Objective: Muscle toxicity is the most significant adverse effect related to statins. The aim of the study was to analyse the clinical course and achievement of...
9.
Maccubbin D, Bays H, Olsson A, Elinoff V, Elis A, Mitchel Y, et al.
Int J Clin Pract
. 2009 Jan;
62(12):1959-70.
PMID: 19166443
Background: Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has complementary lipid-modifying efficacy to statins and cardiovascular benefit, but is underutilised...
10.
Elis A, Rosenmann L, Chodick G, Heymann A, Kokia E, Shalev V
QJM
. 2008 Feb;
101(4):275-80.
PMID: 18296748
Background: It is recommended that in diabetes mellitus patients all risk factors for cardiovascular disease should be controlled. Aim: To evaluate the rate of reaching all glycemic, lipids and blood...